Peripapillary Microvascular and Neural Changes in Diabetes Mellitus: An OCT-Angiography Study by S. Vujosevic et al.
Retina
Peripapillary Microvascular and Neural Changes in
Diabetes Mellitus: An OCT-Angiography Study
Stela Vujosevic,1 Andrea Muraca,1 Valentina Gatti,1 Luca Masoero,2 Marco Brambilla,3 Barbara
Cannillo,3 Edoardo Villani,4,5 Paolo Nucci,4,5 and Stefano De Cilla`1,6
1Eye Unit, University Hospital Maggiore della Carita’, Novara, Italy
2Medical School, University East Piedmont ‘‘A. Avogadro’’, Novara, Italy
3Medical Physics, University Hospital Maggiore della Carita`, Novara, Italy
4University Eye Clinic San Giuseppe Hospital, Milan, Italy
5Department of Clinical Science and Community Health, University of Milan, Milan, Italy
6Department of Health Science, University East Piedmont ‘‘A. Avogadro’’, Novara, Italy
Correspondence: Stela Vujosevic,
University Hospital Maggiore della
Carita`, Eye Unit, Corso Mazzini 18,
28100 Novara;
stela.vujosevic@gmail.com.
Submitted: May 27, 2018
Accepted: September 19, 2018
Citation: Vujosevic S, Muraca A, Gatti
V, et al. Peripapillary microvascular
and neural changes in diabetes melli-
tus: an OCT-angiography study. Invest
Ophthalmol Vis Sci. 2018;59:5074–
5081. https://doi.org/10.1167/
iovs.18-24891
PURPOSE. To evaluate peripapillary vessel density and morphology in patients with diabetes
mellitus (DM) without clinical signs of diabetic retinopathy (DR) and with mild, non-
proliferative DR and to correlate with peripapillary nerve fiber layer (NFL) thickness.
METHODS. One hundred seventeen eyes (34 healthy controls, 54 patients with DM without DR
[noDR group] and 24 patients with mild DR [DR group]) were prospectively evaluated. All
subjects underwent peripapillary and macular optical coherence tomography angiography
(OCT-A). Peripapillary NFL thickness was also recorded. OCT-A slab of radial peripapillary
plexus (RPC) and macular superficial capillary plexus (SCP) were analysed in order to
calculate perfusion density (PD) and vessel density (VD). Further an image analysis of RPC
slab was performed to identify number of branches (NoB) and total branches length (tBL).
RESULTS. In peripapillary area there was a significant decrease in VD (P ¼ 0.003), NoB (P <
0.001), and tBL (P < 0.001) in noDR group versus controls; PD values were not different
among groups (P ¼ 0.126); there was a significant decrease in average NFL thickness in DR
versus controls (P ¼ 0.008) and in the inferior quadrant in noDR group versus controls (P ¼
0.03); there was a significant correlation between OCT-A and NFL thickness values (q ranging
from 0.19–0.57). In macular region PD and VD were decreased only in DR group (P < 0.05).
CONCLUSIONS. There are early changes in the peripapillary vessel morphology and VD of the
RPC in patients with DM without DR that correlate to NFL thinning. Earlier changes in
superficial vessel density are documented in the peripapillary than in the macular region.
These data may confirm a coexistence of an early neuronal and microvascular damage in
patients with DM without clinical signs of DR.
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Diabetic retinopathy (DR) is the leading cause of visualimpairment in patients with diabetes mellitus (DM).1 DM
affects all cell types in the retina, as reported by numerous
experimental and clinical studies.2–7 At the microvascular level,
modifications on pericytes and basement membrane, and
endothelial cell loss ultimately lead to the alterations of the
blood–retinal barrier.8,9 There are microglial cell activation and
neuronal apoptosis in the retina in DM.3,4,10–15 In the
peripapillary region, in patients with DM, these neural
alterations can be clinically documented as a reduction of the
retinal nerve fiber layer (NFL) thickness.16–19
The radial peripapillary capillary plexus (RPC), present only
in the peripapillary region, has an important role in maintaining
neuronal health.20–22 RPC has straight and long vessels with no
frequent anastomoses, as documented by histology.21 Previous-
ly, fluorescein angiography was used to image this vascular
structure; however, this is an invasive technique that only
produces images of total vascularization, obscuring the details
of individual vascular layers. Optical coherence tomography
angiography (OCT-A) is a noninvasive and reproducible imaging
technique, which has recently been used to study macular and
peripapillary vascular structure with a heretofore impossible
level of detail and clarity.23–25 Different authors have used OCT-
A to evaluate vascular density of RPC in healthy humans and in
subjects with glaucoma.26–33 No quantitative data are currently
available on microvascular alterations in the peripapillary area
in patients with DM. In this population, the density of vascular
structures was evaluated with OCT-A only in the macular
region.34–37 Dimitrova et al.34 have measured vessel density in
superficial and deep capillary plexuses in the macula, reporting
a decrease in density in patients with DM without DR as
compared with healthy subjects. Kim et al.35 added to this
vascular density measurement, an evaluation of the vascular
morphology and complexity in patients with DR, finding
alterations of these parameters with the worsening of DR.
To the best of our knowledge, there are no studies that
describe vascular density of RPC and its morphology in patients
with DM.
The purpose of this study was to evaluate the features of the
RPC in the peripapillary region in patients with DM without
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clinical signs of DR and with mild nonproliferative DR and to
correlate it with peripapillary NFL thickness.
MATERIALS AND METHODS
Patients and Study Design
In this cross-sectional, comparative, and consecutive case–
control study, 117 subjects (117 eyes) were prospectively
evaluated, consisting of 34 healthy controls, 59 patients with
DM without clinical signs of DR (noDR group) and 24 patients
with mild nonproliferative DR (DR group). The right eye was
included in the study. In case of artifacts or poor quality in the
right eye images, the left eye was used. All patients with DM
were enrolled from the Medical Retina service of the University
Hospital Maggiore della Carita` in Novara. Inclusion criteria
were patients over age 18 with DM (type 1 and type 2,
diagnosis confirmed by the diabetologist) without clinical signs
of DR, or with mild nonproliferative DR according to the
international classification (diagnosis made on slit-lamp fundus
examination by the same ophthalmologist, SV, and documented
on color fundus photograph of the macula)38; healthy subjects
(with normal glucose test, control group); no history of ocular
hypertension (IOP < 21 mm Hg), nor neurodegenerative
disease (e.g., multiple sclerosis, Alzheimer disease, Parkinson,
etc). Major exclusion criteria were previous intraocular
treatment (laser, intravitreal injections, and vitreoretinal
surgery); cataract surgery within 6 months; any topical
therapy; refractive error greater thanþ4 diopters (D); moderate
or severe DR or diabetic macular edema; smoking; ischemic
heart disease; and significant media opacity that precluded
good quality fundus imaging and examination. For both
controls and DM patients, series of examinations were
performed, beginning with taking blood pressure measure-
ments, collecting anamnestic data, including type of DM,
recording the value of glycated hemoglobin (HbA1c), and
performing a complete ophthalmologic examination with best-
corrected visual acuity determination, IOP measurement, slit-
lamp fundus examination in mydriasis with 90-D lens (for
grading the absence/presence of DR), and color fundus
photograph of the macula. On the same day, OCT and OCT-A
exams were performed in mydriasis. This study followed the
tenets of the Declaration of Helsinki and was approved by the
institutional ethics committee. Signed informed consent was
obtained from all patients.
Imaging
Spectral-Domain Optical Coherence Tomography and
Optical Coherence Tomography Angiography. OCT and
OCT-A images were taken using a swept-source OCT, DRI OCT
Triton plus (Topcon Medical Systems Europe, Milano, Italy).
This instrument uses 1050-nm wavelength light, with a
scanning speed of 100,000 A-scans/second. The following
three types of scans were performed: an OCT three-dimen-
sional (3D) disc map covering an area of 636 mm centered on
the papilla, an OCT-A maps covering 4.5 3 4.5 mm area
centered on the papilla, and a 33 3-mm area centered on the
fovea.
Spectral-Domain Optical Coherence Tomography
Segmentation and Measurement. Using the 3D disc scan,
peripapillary NFL thickness was measured by automated
placement and scanning of a circle with 3.4 mm in diameter,
centered on the papilla. Average thicknesses of total peripap-
illary NFL and superior, inferior, nasal, and temporal quadrants
were determined with automatic segmentation with DRI OCT
Triton plus OCT instrument (software version 10.07.003.03).
Optical Coherence Tomography Angiography Scans
Evaluation. Peripapillary and macular OCT-A scans were used
for quantitative evaluations. Peripapillary evaluation was
performed at the level of the radial peripapillary capillary
plexus (RPC); the macular evaluation was performed at the
level of the superficial capillary plexus (SCP). The built-in
software segmentation algorithm was used to define RPC and
SCP on en face OCT angiograms. The RPC slab was obtained
from the top of internal limiting membrane (ILM) to 70.2 lm
below it. The SCP slab was obtained from the ILM to 15.6 lm
above the inner plexiform layer/inner nuclear layer (IPL/INL)
interface. Images with artifacts and those with signal strength
index below 50 were excluded. Only good quality images were
considered.
Quantitative peripapillary and macular parameters included
the following: (1) perfusion density (PD; the total area
occupied by the vessels); (2) vessel density (VD; the relative
value of the total length of the vessels); and Branch analysis of
skeletonized images, in particular (3) the number of branches
(NoB), and (4) total branches length (tBL). All these parameters
were evaluated with ImageJ version 1.51 software (http://im
agej.nih.gov/ij/; provided in the public domain by the National
Institutes of Health, Bethesda, MD, USA).35,39–41
ImageJ Analysis. OCT-A images were opened in ImageJ
analysis software (Fig. 1). All OCT-A images were converted
into 8-bit files (3203 320 pixels; one-pixel macula » 9.3753
9.375 lm2; one-pixel papilla » 14.063 14.06 lm2). All images
underwent automatic ‘‘default’’ threshold available in the
ImageJ software to neutralize the background noise. The image
was then converted into a binarized black-and-white image.
RPC slab images were analyzed eliminating the optic disc from
the analysis (the region of interest was manually delineated by
2 evaluators and confirmed by the expert ophthalmologist) to
remove the large vessels of the optic disc. This binary image
was used to calculate PD (number of pixels of vessels/total
pixels of the analyzed area).39 The binarized image was used to
create a skeletonized image to measure the statistical length of
moving blood column, or VD [(number of pixels of vessels)3
(scan width in mm/320) / (area in mm2)], as previously
described.38 In this skeletonized image all vessels even large
vessels are only one pixel wide. The skeletonized image was
examined using Skeleton Analysis for the ImageJ application,
AnalyzeSkeleton (Fig. 2). This plugin tags all pixels in a
skeleton image, counts all their junctions, triple and quadruple
points, and branches, and then measures average and
maximum lengths.40,41 When activating the plugin, a comple-
mentary results table called ‘‘branch information’’ is shown.
From this automatic analysis we considered only two
parameters, tBL and NoB.
In order to compare PD and VD with NFL thickness in each
peripapillary quadrant (superior, inferior, nasal, and temporal),
the binarized and skeletonized OCT-A images of the peripap-
illary region were divided into four quadrants, by two
orthogonal lines, which crossed at the center of the papilla,
using ImageJ. All images were saved and analyzed in
anonymous and masked fashion.
Statistical Analysis
The clinical and demographic variables were compared among
the three subject groups using one-way ANOVA for continuous
variables and Fisher’s exact test for categoric variables. Due to
the relatively limited sample size in our study, we chose to
consider baseline covariates (PA and age) in the analysis instead
than in the patient selection phase. The variables which
resulted significantly different among groups were considered
as covariates in the following analyses, which were performed
using analysis of covariance (ANCOVA), to compare clinical
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variables among the three subject groups by adjusting for the
level of the covariates.42,43
The means of populations were estimated as least squares
means, which are the best linear estimates for the marginal
means in the ANCOVA design. In case of an overall statistically
significant (P < 0.05) or borderline significant difference
among subject groups, pairwise comparisons among the three
groups were done using the Scheffe´ test.44 The correlation
among nonnormally distributed variables were assessed using
the Spearman’s rank test and expressed through the nonpara-
metric Spearman’s correlation coefficient q. All the analyses
were performed using Statistical version software 6.0 (StatSoft,
Inc., Tulsa, OK, USA), using a two-sided type I error rate of P¼
0.05.
RESULTS
Of 117 subjects (117 eyes, 100 were right eyes and 17 left
eyes), 34 were healthy controls, 59 patients with DM without
signs of DR, and 24 patients with mild-DR. In Table 1
represents patients’ systemic characteristics (age, DM duration,
HbA1c, systolic blood pressure, diastolic blood pressure, IOP,
insulin treatment). Age and systolic blood pressure (SBP)
showed statistically significant differences among the groups
with ANOVA analysis. Table 2 shows values of NFL thickness in
the peripapillary region (NFL average thickness and in each
quadrant, superior, inferior, nasal, temporal). After adjusting for
age and SBP there was a statistically significant difference in
NFL thickness in the superior (P ¼ 0.025) and inferior (P ¼
FIGURE 1. ImageJ analysis of the RPC image. (A) RPC slab image, (B) ImageJ binarization, (C) optic disc manually removed, and (D) ImageJ
skeletonization.
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0.004) quadrants among the three groups. Pairwise compari-
sons evidenced significant differences between controls and
DR in the superior quadrant (P¼ 0.025) and between controls
and noDR (P¼0.03), and between noDR and DR (P¼0.006) in
the inferior quadrant. Although not statistically significant,
there was a clear trend of decreasing values for NFL average
thickness from controls to noDR, and to DR (P ¼ 0.096).
Pairwise comparisons evidenced significant differences be-
tween controls and DR (P¼ 0.008). In the peripapillary region
there was a trend of decreasing VD and PD values among
controls, noDR and DR, although not reaching statistical
significance (Table 3). Pairwise comparisons showed signifi-
cant differences in VD between DR and noDR (P ¼ 0.03) and
between noDR and control (P ¼ 0.003). NoB values in the
peripapillary region showed a statistically significant decrease
from control, to noDR and to DR (P ¼ 0.025). Pairwise
comparisons showed significant differences between control
and noDR (P < 0.001) and between noDR and DR (P¼ 0.03).
TBL values in the peripapillary region showed a decreasing
trend from control to DR, although not statistically significant.
Pairwise comparisons showed significant differences between
control and noDR (P < 0.001) and between noDR and DR (P¼
0.003). In the macular region there was a trend of decreasing
PD and VD values among control, noDR and DR patients,
almost reaching statistical significance (PD P ¼ 0.081, VD P ¼
0.058). Pairwise comparisons showed significant differences in
FIGURE 2. AnalyzeSkeleton analysis. Automatic analysis of skeletonized images. From this analysis the number of branches and branch’s length can
be counted. (A) Skeletonized Image with removed optic disc region that was analyzed with plugin AnalyzeSkeleton. (B) The plugin tagged pixels in
the skeleton image (end-point pixels are displayed in blue, slab pixels in orange and junction pixels in purple). (C) An extra output image
containing each skeleton labeled that corresponded to a skeleton ID from the associated table results (not shown). From the table, the number of
branches and the total length of branches were determined. (D) Output image of the shortest (magenta) and the longest (white) path.
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PD between DR and noDR (P¼0.03) and DR and controls (P <
0.001); in VD between DR and noDR (P ¼ 0.02) and DR and
controls (P < 0.001). Table 4 shows correlations between OCT-
A parameters in the peripapillary region (PD, VD, NoB, and
tBL) and NFL thickness values (average and separately in each
quadrant). All the correlations were statistically significant with
a Spearman’s Rank Coefficient q ranging from a minimum
value of 0.19 for the correlation between PD inferior (PDi) and
NFL inferior (NFLi) and a maximum correlation of q¼ 0.57 for
the correlation between VD and NFL average.
DISCUSSION
In this study, we evaluated retinal capillary plexus in the most
superficial layer (RPC) in the peripapillary region in healthy
subjects and in patients with DM without DR and with mild
nonproliferative DR using swept-source OCT-A. We found a
significant decrease in VD, NoB and tBL in the peripapillary
area in patients with DM, even without clinical signs of DR
when compared with healthy subjects. PD values in the
peripapillary region were not different among the groups.
However, VD is considered to be more accurate parameter
than PD in measuring retinal vascular changes, as the
skeletonized image normalizes the diameter of larger vessels
with that of capillaries, removing the influence of vessel size
on retinal perfusion measurements.35,39,45
The PD and VD were also evaluated in the macular region in
SCP, and both parameters were found decreased in patients
with mild DR versus controls and in mild DR versus noDR
group. In the macular region, only SCP was evaluated, in order
to evaluate the most superficial vascular plexus in both areas.
Moreover, SCP is considered more easily evaluated for
differentiating healthy eyes from eyes with DR as previously
reported.46,47 The present data are in agreement with
previously published data evaluating VD in the macular region
and reporting a significant decrease in patients with DR versus
healthy controls.35,48 Some authors have described a decrease
in VD even in patients with DM without DR versus control.34,47
Lei et al.47 evaluated only superficial capillaries on images
having very different signal strength among groups, that might
have influenced the analyses, as reported by the same authors.
Dimitrova et al.34 described a significant difference in macular
VD between patients with DM without DR and healthy
subjects. However, data from the present study cannot be
directly compared with the data from Dimitrova et al.34 due to
differences in subjects’ ethnicity (only Asian patients were
included) number of evaluated subjects, duration of DM, and
the use of different OCT-A machines.
Currently, there is no available OCT-A data on peripapillary
VD in patients with DM in the literature. We found a significant
decrease in VD in the peripapillary region even in patients
without DR while, in macular region, this decrease was found
only when clinical signs of DR were present. This could
indicate that peripapillary microvascular alterations in VD
occur earlier than in the macular region, even before the
appearance of clinically visible signs of DR; consequently,
changes in RPC in the peripapillary region could represent an
early preclinical sign of diabetic microvascular disease. This
could be explained due to the peculiar anatomic conformation
of the peripapillary plexus,21 made up of capillaries with long
straight paths and rare anastomotic connections, remaining
strictly associated with NFL, and giving important nourishment
to the NFL in this region. These features differentiate RPC from
SCP in the macular region, that forms a dense capillary
network with numerous anastomoses also with the underlying
plexuses (intermediate and deep capillary plexuses).21,23,24
The present work documents a significant reduction in NoB
and tBL in patients with DM without signs of DR when
compared with healthy subjects in the peripapillary region. This
is the first study that evaluates retinal vasculature parameters
with the aid of ImageJ plug-in, AnalyzeSkeleton. Previous studies
have demonstrated the importance and reproducibility of this
method of analysis for the automatic reconstruction of biological
tissues in order to provide morphologic phenotype information,
but none of these studies used AnalyzeSkeleton to evaluate
retinal vascularization.40,41 Arganda-Carreras et al.40 previously
described the process of the algorithm of ImageJ plug-in,
AnalyzeSkeleton. The system of analysis is completely automatic
and shows all branches of retinal vessels and their length, giving
morphologic information about retinal vascularization and its
modifications in retinal diseases.
Given the fractal nature of retinal vascularization, many
authors have tried to study its features using fractal analysis,
that calculates the so-called fractal dimension (FD), a mathe-
matic parameter that describes the complexity of a biological
structure, such as branching angle, tortuosity, and vessel
complexity.49–51 Different authors have demonstrated alter-
ations of FD in patients with DR using color and red-free
fundus photographs and fluorescein angiography.52–55 These
authors evaluated only large retinal vessels reporting both
increased and decreased FD in DR. However, the previously
mentioned technology did not allow for evaluation of
morphologic changes at the capillary level, which can be
easily evaluated using OCT-A.23 Recently, there has been
several papers on evaluation of vessel FD in the macular
region using OCT-A in patients with DM.35,39,56,57 Reif et al.39
TABLE 1. Sample Characteristic of the Subjects and Patients
Parameter
Controls
(N ¼ 34)
noDR
(N ¼ 59)
DR
(N ¼ 24)
ANOVA
P Value*
Age, y 43.9 (11.9) 53.0 (18.9) 68.7 (12.3) <0.001
DM duration, y n.a. 10.5 (11.0) 11.2 (6.5) 0.77
HbA1c (%) n.a. 6.8 (0.8) 6.9 (0.6) 0.81
SBP, mm Hg 130.1 (2.0) 138.3 (5.7) 141.8 (5.3) <0.001
IOP, mm Hg 15.4 (2.3) 14.9 (2.1) 15.5 (2.1) 0.28
Insulin (% of
patients)
n.a. 54.2 62.5 0.62†
Values are represented as mean (SD). n.a., not applicable.
* One-way ANOVA: comparison among controls, patients with DM
without DR, and patients with DR.
† Fisher’s Exact test was used. All patients with systemic
hypertension were on lowering medication.
TABLE 2. Values of NFL Thickness in the Peripapillary Region
Parameter
Controls
(N ¼ 34)
noDR
(N ¼ 59)
DR
(N ¼ 24)
ANCOVA
P Value*
NFL
Average 108.5 (9.0) 105.8 (11.8) 99.1† (12.6) 0.096
Superior 130.4 (12.6) 126.8 (17.5) 118.0‡ (21.3) 0.025
Inferior 139.1 (15.9) 134.8§ (18.7) 123.3jj (19.0) 0.004
Nasal 85.5 (18.6) 84.4 (13.9) 82.5 (16.0) 0.769
Temporal 78.8 (12.7) 77.0 (14.8) 72.4 (10.4) 0.200
* ANCOVA analyses by adjusting for age and SBP: comparison
among controls, patients with DM without DR, and patients with DR.
Comparison vs. controls:
† Scheffe` test, P ¼ 0.008.
‡ Scheffe` test, P ¼ 0.025.
§ Scheffe` test, P ¼ 0.03.
Comparison vs. patients with DM without DR:
jj Scheffe` test, P¼ 0.006.
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were the first to describe capillary FD with a prototype OCT-A
in an mouse ear model. Other authors described a decrease in
FD in patients with DM (type 1 and type 2) from mild DR to
proliferative DR.35,56 As FD geometry mirrors the physiologic
branching of the retinal vascular tree, the FD may provide
better insights into pathogenesis of DR. Moreover, FD used
with other quantitative analyses (such as VD, areas of
nonperfusion, etc.) may help for disease risk stratification,
and evaluation of treatment. Chen et al.57 evaluated FD in
patients with DM without DR in the macula and found a
significant decrease versus healthy controls. Moreover, this
reduction was significant only in the deep capillary plexus.
This may be due to specific anatomy of the DCP (greater
density of smaller vessels in the DCP versus SCP), in which
vascular constriction of the DCP in the macular region may be
an earlier compensating mechanism than in the SCP for
decreased blood flow and resulting hypoxia and ischemia in
patients with DM.57
Even if performed with a different method of analysis and in
a different retinal region (peripapillary area), the present data
confirm the importance of vessel morphology evaluation in the
study of patients with DM before the appearance of clinical
signs of DR. Further longitudinal studies would be necessary to
compare the present data obtained with AnalyzeSkeleton with
peripapillary fractal analysis, never performed before in this
region in patients with DM, in order to define if the number of
branches is more predictive of DR development than
complexity of capillaries.
Previously, both experimental and clinical studies have
reported on the presence of early neurodegeneration in the
retina in patients with DM without clinical signs of
DR.3,4,13–15,58 In the present study, we found a significant
decrease in average NFL thickness and in the superior quadrant
of patients with DR versus controls. Instead, very early
reduction in NFL thickness was found in the inferior quadrant,
even in patients with DM without DR versus controls. These
data agree with recent clinical works on peripapillary average
NFL thickness in patients with DM and with or without
DR.14,59
In the present study, there is a significant correlation
between OCT-A parameters (PD, VD, NoB, and tBL) and NFL
thickness values (average and separately in each quadrant) in
the peripapillary region. These data are in agreement with
previous postmortem histologic studies that described a
correlation between RPC volume and NFL thickness in healthy
human donor retinas.22 Mase et al.26 described this correlation
in healthy subjects using OCT-A, suggesting that RPC is the
most important structure in maintaining NFL integrity. The
decrease and correlations among OCT-A parameters and NFL
thickness in the peripapillary region may confirm a coexis-
tence of an early neuronal and microvascular damage in
patients with DM without clinical signs of DR. The exact
relationship (including also the temporal one) between the
neuronal and the microvascular damage remains to be further
evaluated, and certainly confirms the need to move beyond the
pure microvascular classification of DR and to integrate also
neuronal damage into classification of diabetic retinal dis-
ease.60
The major limitation of this study includes a cross-sectional
design without longitudinal data especially in determining the
TABLE 4. Correlations Between OCT-A Parameters in the Peripapillary
Region (PD, VD, NoB, and tBL) and NFL Thickness Values (Average and
Separately in Each Quadrant)
NFL
Parameter Average Superior Inferior Nasal Temporal
All subjects
PD 0.43*
PDs 0.34*
PDi 0.19*
PDn 0.26*
PDt 0.40*
VD 0.57*
VDs 0.43*
VDi 0.34*
VDn 0.30*
VDt 0.44*
tBL 0.47*
NoB 0.48*
s, superior; i, inferior; n, nasal; t, temporal.
* Spearman’s rank coefficient.
TABLE 3. Quantitative OCT-A Parameters in the Peripapillary and Macular Regions
Parameter
Controls
(N ¼ 34)
noDR
(N ¼ 59)
DR
(N ¼ 24)
ANCOVA
P Value*
PD
Peripapillary 0.37 (0.03) 0.35 (0.03) 0.33† (0.05) 0.126
Macular 0.31 (0.04) 0.29 (0.03) 0.27‡** (0.02) 0.081
VD
Peripapillary 0.20 (0.01) 0.18§ (0.02) 0.17†† (0.03) 0.132
Macular 0.15 (0.03) 0.14 (0.01) 0.12jj‡‡ (0.01) 0.058
NoB 202.1 (11.4) 189.0¶ (17.8) 117.4** (34.8) 0.025
tBL 344639 (65016) 299644# (49931) 274465§§ (73692) 0.142
* ANCOVA analyses by adjusting for age and SBP: comparison among controls patients with DM without DR, and patients with DR.
Comparison vs. controls:
† Scheffe` test, P < 0.001.
‡ Scheffe` test, P < 0.001.
§ Scheffe` test, P ¼ 0.003.
jj Scheffe` test, P < 0.001.
¶ Scheffe` test, P < 0.001.
# Scheffe` test, P < 0.001.
Comparison vs. patients with DM without DR:
** Scheffe` test, P¼ 0.03.
†† Scheffe` test, P ¼ 0.03.
‡‡ Scheffe` test, P ¼ 0.02.
§§ Scheffe` test, P¼ 0.003.
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prognostic value of the evaluated parameters for development
of DR. The pairwise comparisons tests employed were already
designed to control familywise error rates in the absence of any
significant prior omnibus analysis. However, we chose to run
the pairwise comparisons only in the case of overall
significance or borderline significance as an over protection
against potential type I error. We acknowledge that given the
small study with multiple comparisons, the potential of having
false-positive results may still exist and therefore the results
should be considered more as an insight provided to the reader
with preliminary data, than a definitive conclusion that would
need further confirmation from larger studies.
In conclusion, this study documents very early changes in
the peripapillary vessel density and morphology (VD, NoB,
tBL) of the most superficial capillary plexus (RPC) in patients
with DM without DR and correlate it to NFL thinning. Earlier
changes in superficial vessel density are documented in the
peripapillary region than in the macular region. Specific
anatomic characteristics of the RPC may be responsible of
greater and earlier microvascular susceptibility to chronic
hyperglycemia in DM, then in the macular region. Further,
longitudinal studies linking all these evaluated OCT-A param-
eters to the neuronal damage (such as thinning of the NFL)
might help in better understanding of microvascular and
neuronal relationship in DM and in finding a predictive marker
of DR development.
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